IP Library › Assignment 063967/0472
Patent Assignment
Reel/Frame 063967/0472

Assignment of Assignor's Interest

Recorded: 2023-06-15 Pages: 14
Assignors
FRANOVIC, ALEKSANDRA
Executed: 2023-04-23
MARTIN, ERIC
Executed: 2023-04-17
MILLER, NICHOL L. G.
Executed: 2023-05-09
MURPHY, ERIC
Executed: 2023-05-12
WILLIAMS, RICHARD THOMAS
Executed: 2023-05-19
KOBAYASHI, KEN
Executed: 2023-05-09
Assignee
KINNATE BIOPHARMA INC.
12830 EL CAMINO REAL, SUITE 150, SAN DIEGO, CALIFORNIA, 92130
Covered Property (1)
Treatment of Cancer with a Raf Inhibitor
Application: 18/296,726 →
Publication: US 2023/0255977
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 4, 2024
From: KINNATE BIOPHARMA INC.
To: PIERRE FABRE MÉDICAMENT, SAS
Reel/Frame 066638/0147 →
Corrective Assignment to Correct the Correct the Receiving Party Data Company Name Is: Pierre Fabre Medicament Previously Recorded at Reel: 66638 Frame: 147. Assignor(S) Hereby Confirms the Assignment. Sep 11, 2024
From: KINNATE BIOPHARMA INC.
To: PIERRE FABRE MÉDICAMENT
Reel/Frame 068939/0656 →